A NEW HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND TABLET DOSAGE FORM

  • B. V. SUMA Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bangalore, India
  • DEVESWARAN R. Department of Pharmaceutics, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bangalore, India, Drug Design and Development Centre, M. S. Ramaiah University of Applied Sciences, Bangalore, India
  • PREMNATH SHENOY Drug Design and Development Centre, M. S. Ramaiah University of Applied Sciences, Bangalore, India

Abstract

ABSTRACT


Objective: To develop a new simple, selective and precise high-performance thin layer chromatographic method for determination of Dapagliflozin (DAPA) in bulk and tablet dosage form


Methods: The present study describes development and validation of High performance thin layer chromatographic method for DAPA. The chromatographic separation was carried out on Merck precoated silica gel aluminium plate 60 F254 using Chloroform: Methanol (9:1v/v) as mobile phase. Quantitative determination of drug was carried out by densitometric scanning of plates at 223 nm using Camag TLC Scanner.


Results: The chromatographic condition shows compact band with the retention factor for dapaglifloxin as 0.21 ± 0.004. The method was validated as per ICH guidelines for linearity, accuracy, precision and robustness. Response was found to be linear in the concentration range of 400 ng/ band to 1200 ng/band with linear regression value of 0.9953 with respect to peak area and concentration value The LOD and LOQ was found to be 1.2083 ng/band and 3.6616ng/ band. The percentage assay was found to be 100±0.05.


Conclusion: This method under statistical analysis proved a selective, repeatable and accurate analysis of the drug. This method can be used for quantitative analysis of dapaglifloxin in the bulk drug and in tablet.


 


 

Keywords: Dapagliflozin, HPTLC, Method development, Validation

Downloads

Download data is not yet available.

References

1. https://www.drugbank.ca/drugs/DB06292(Accessed on June 2018).
2. Gajanan VM, Krishna RG, Atul TH. Estimation of dapagliflozin from its tablet formulation by UV-Sspectrophotometry. Pharm Methods 2017; 8(2): 102-107.
3. Karuna PC, China E, Basaveswara Rao MV. Unique UV spectrophotometric method for reckoning of Dapagliflozin in bulk and pharmaceutical dosage forms, J. Chem. Pharm. Res. 2015; 7(9): 45-49
4. Sanagapati M, Dhanalakshmi K, Nagarjunareddy G, Sreenivasa S: Development and Validation of a RP-HPLC Method for the Estimation of Dapagliflozin in API .Int J Pharm Sci Res 2014; 5(12): 5394-97.
5. Sanagapati Manasa, Dhanalakshmi K, Nagarjuna Reddy G, Sreenivasa S Method Development and Validation of Dapagliflozin in API by RP-HPLC and UV-Spectroscopy Int. J. Pharm. Sci. Drug Res. July-September, 2014:6 (3):250-252
6. Asmita M, Chandanam SR, Akkamma HG, Arpitha S, Krishna PT. Analytical method development and statistical validation of dapagliflozin in tablet dosage form and bulk drug. Ind Res J Pharm Sci 2018; 16: 1344-1356.
7. Gunasekar M, Ahmed MI, Zeyad MA. Stability indicating RP-HPLC method development for simultaneous determination and estimation of dapagliflozin in raw and tablet formulation. Chemistry Res Journal 2018;3(2):159-164.
8. Jitendra D, Sundeep K, Sajal KJ, Amjad K. A new RP-HPLC method development and validation of dapagliflozin in bulk and tablet dosage form. Int J Drug Del Res. 2017; 9: 2-4.
9. Mante GV, Hemke AT, Umekar MJ. RP-HPLC method for estimation of dapagliflozin from its tablets. Int J of Chem Tech Res 2018;11(01): 242-248.
10. Mitali V, Chirag JP, Patel MM. Development and stability indicating HPLC method for dapagliflozin in API and pharmaceutical dosage form. Int J Applied Pharmaceutics 2017; 9(5):33-41.
11. Sanjeev KS, Bonagani N, Vadicherla S, Merugu M. Stability indicating RP-HPLC method development and validation of dapagliflozin in bulk and pharmaceutical dosage form. Indo American Journal of Pharmacy. 2017; 3(6): 321-329.
12. Subrata S, Vipul PP. Method development and validation of dapagliflozin drug in bulk and tablet dosage form by RP-HPLC. Int J Pharma Res and Health Sciences. 2017; 5(4): 1755-59.
13. Aubry AF, Gu H, Magnier R, Morgan L, Xu X, Tirmenstein M, Wang B. Validated LC-MS/MS methods for the determination of dapagliflozin, A sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma. Bioanalysis. 2010; 2(12):2001-2009.
14. Sally Nasser, Ismail Salama, Samia M. Mostafa, Mohamed Saleh Elgawish. Comparative high-performance liquid chromatographic and high-performance thin-layer chromatographic study for the simultaneous determination of dapagliflozin and metformin hydrochloride in bulk and pharmaceutical formulation, J of Planar Chromatography - Modern TLC. 2018; 31(6): 469-476.
15. Shveta H, Parmar, Shailesh VL, Sachin BN. Development and validation of UV-spectroscopic first derivative and high performance thin layer chromatography analytical methods for simultaneous estimation of Dapagliflozin propanediol monohydrate and saxagliptin hydrochloride in synthetic mixture. Eur J Biomed Pharm Sci. 2018; 5(5): 668-681.
16. ICH, Q2B Validation of Analytical Procedure: Methodology, in: Proceeding of the International Conference on Harmonization, Geneva, March 1996. Accessed from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guidelines.
Statistics
42 Views | 46 Downloads
How to Cite
SUMA, B. V., D. R., and P. SHENOY. “A NEW HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND TABLET DOSAGE FORM”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 11, no. 8, July 2019, pp. 58-63, doi:10.22159/ijpps.2019v11i8.34339.
Section
Original Article(s)